OncLiveSeiwert Summarizes Immunotherapy Advances in Head and Neck CancerOncLiveThe treatment landscape of head and neck cancer has changed significantly over the past year. With the approval of pembrolizumab (Keytruda) in August 2016 and nivolumab (Opd… Continue reading
OncLiveSeiwert Summarizes Immunotherapy Advances in Head and Neck CancerOncLiveThe treatment landscape of head and neck cancer has changed significantly over the past year. With the approval of pembrolizumab (Keytruda) in August 2016 and nivolumab (Opd… Continue reading
Fred Hutch News ServiceImmunotherapy drug becomes first therapy approved by FDA for rare skin cancerFred Hutch News ServiceTom Judd, photographed with his wife Karen Judd, saw his advanced Merkel cell carcinoma shrink by more than 90 percent on an immu… Continue reading
|
The stem cell procedure that may change the sports medicine field in 2017 — 5 observations
Becker’s Orthopedic & Spine based Andrews Sports Medicine & Orthopedic Center said, “Stem cells are a way to try to deliver the chemicals to cells and the chemical attractive factors to that area to allow the body to heal that tissue. That’s what PRP was used for as well. Stem … |
|
GenScript Partners With iGEM to Expand Synthetic Biology Community in China
Digital Journal GenScript USA, Inc., the number one global provider of gene synthesis services, is announcing a partnership with iGEM to engage and expand the synthetic biology research community in China. This will be the ninth year GenScript has supported the … |
|
GenScript Partners With iGEM to Expand Synthetic Biology Community in China
Digital Journal GenScript USA, Inc., the number one global provider of gene synthesis services, is announcing a partnership with iGEM to engage and expand the synthetic biology research community in China. This will be the ninth year GenScript has supported the … |
FiercePharma |
Pfizer’s Immunotherapy for Skin Cancer Gets FDA Approval
Yahoo Finance With the FDA approval, avelumab becomes the first immunotherapy option for the treatment of metastatic MCC, a rare form of skin cancer, which until now was being treated only with chemotherapy. Only less than 50% of the metastatic MCC patients survive … Pfizer, Merck KGaA score watershed FDA nod on cancer immunotherapy BavencioFiercePharma FDA approves Pfizer, German Merck immunotherapy for skin cancerReuters Pfizer (PFE) and Merck (MRK) BioPharma Unit Get FDA Approval for BAVENCIO® (Avelumab), the 1st Immunotherapy …StreetInsider.com Bloomberg –Financial Times –FDA.gov all 35 news articles » |
|
Man with 45% burns healed with stem cell treatment
India.com Mumbai, March 24 (IANS) A 45-year-old man — suffering from 45 per cent burns due to a chemical spill at work — has been healed with stem cell treatment, said the authorities at a hospital here on Friday. Ram Naik (name changed) was brought to city … |